genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
Ariad Pharmaceuticals
A-Lists
Top Eight Asia Biopharma Clusters 2017
Cancer
SEC Charges Two Ex-Ariad Executives, Husband of a Third with Insider Trading
Industry News
Takeda Slicing Ariad Workforce After Acquisition
Cancer
Incyte Partners with Penn on Cancer Immunotherapy Research
Industry News
Takeda to Acquire Ariad Pharmaceuticals for $5.2B
Industry News
Novartis and Ariad Separately Report Positive ALK Inhibitor Results
Industry News
Incyte Buys ARIAD’s European Operations for Up to $289M+
Industry News
Ariad Axing 90 Jobs, 25% of Workforce
A-Lists
Nine Takeover Targets of 2015
Cancer
Ariad to Receive Up-to $200M in Royalty Deal
1
2
3
Page 1 of 3
Scroll Up
Scroll Up
